HCPCS Level II J2267: Mirikizumab-mrkz Injection, 1 mg
HCPCS Level II code J2267 describes an injectable biologic product, mirikizumab-mrkz, dosed as 1 mg per unit, used for subcutaneous or intramuscular administration in outpatient infusion clinics, physician offices, or ambulatory care settings where biologic injections are given. This HCPCS Level II code is assigned to the drug itself for billing drug administration and product reporting separate from the procedure for giving the injection, and is used in claims to indicate dispensing of mirikizumab-mrkz at the specified unit strength for clinical services involving biologic therapy.
Customize your policy alerts
Sign up for hcpcs J2267 policy alerts
Get alerted when payer policies referencing J2267 are released or updated.
Monitor payer policy activity